Nasopharyngeal Colonization and levofloxacin Susceptibility of Streptococcus pneumoniae among Healthcare Workers in a Teaching Hospital in Tehran, Iran by Samadpanah, Maryam et al.
                                                                                                                           Novelty in Biomedicine 




Nasopharyngeal Colonization and levofloxacin Susceptibility of 
Streptococcus pneumoniae among Healthcare Workers in a Teaching 
Hospital in Tehran, Iran 
 
 
Maryam Samadpanah1, Latif Gachkar1, Sara Salarian1, Fahimeh Hadavand1* 
 
1 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
 
Received: 31 December, 2019; Accepted: 31 May, 2020 
Abstract 
Background: Streptococcus pneumoniae commonly asymptomatically colonizes the human upper respiratory tract 
and the carriage rate varies between geographical regions. The colonized individuals are not only at risk of 
infections but also can be a source of transmission of the pathogen. The risk of the droplet or airborne transmission 
of pneumococcal strains healthcare workers is considerable.  The current study aimed to determine the extent of 
nasopharyngeal colonization with S. pneumoniae and their levofloxacin susceptibility at a tertiary hospital in 
Tehran, Iran. 
Materials and Methods: During a six-month period, the nasopharyngeal swab samples collected from 300 
volunteer healthcare workers of Imam Hossein Hospital. Samples screened for S. pneumoniae using standard 
conventional biochemical methods. The minimum inhibitory concentration (MIC) of levofloxacin was 
determined using a commercially available strip antibiotic test according to the clinical laboratory standards 
institute (CLSI) guidelines. 
Results: A total of 19 (6.3%) enrolled healthcare workers were colonized with S. pneumoniae. Amongst the 
enrolled volunteers, nurses had a higher rate of pneumococcal colonization (47.3%) followed by interns (21%) 
and laboratory workers (15.8%). Our analysis revealed that there was a significant correlation between 
smoking and pneumococcal colonization. The antimicrobial susceptibility testing showed that all of the isolates 
were susceptible to levofloxacin (MIC≤2 μg/ml). 
Conclusion: This low rate of pneumococcal colonization amongst healthcare professionals may be attributed to 
the low risk of horizontal transmission of severe pneumococcal infections in the hospital. Additionally, our 
findings indicated that levofloxacin was an effective antimicrobial agent for the treatment of pneumococcal 
infections. 
Keywords: S. pneumoniae, Health care workers, Nasopharyngeal carriage, Colonization, Levofloxacin  
 
*Corresponding Author: Fahimeh Hadavand, Infectious Diseases and Tropical Medicine Research Center, School of Medicine, Shahid 
Beheshti University of Medical Sciences, Velenjak, Shahid Chamran Freeway, Tehran, Iran, Tel: (+98) 911-1777579. Email: 
Fahimehadavand140@gmail.com 
 
Please cite this article as: Samadpanah M, Gachkar M, Salarian S, Hadavand F. Nasopharyngeal Colonization and levofloxacin 




Streptococcus pneumoniae (also called 
pneumococcus) commonly asymptomatically colonize 
the human upper respiratory tract, but occasionally can 
cause a wide range of infections ranging from non-
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invasive infections, such as sinusitis and acute otitis 
media, to serious lethal invasive diseases such as 
pneumonia, septicemia or meningitis1-3. Despite the 
availability of effective antimicrobial agents and the 
application of pneumococcal vaccines, the world 
health organization (WHO) reported that 
pneumococcal diseases were responsible for about 1.6 
million deaths around in 2008 worldwide4. Young 
children and the elderly are particularly vulnerable to 
pneumococcal disease due to the lack of an adequate 
immune system and recurrent contacts to 
pneumococcal strains5. 
The nasopharyngeal carriage rate of pneumococcus 
varies between geographical regions6. As a matter of 
fact, the clinical outcome of pneumococcal infections 
are preceded by asymptomatic colonization of the 
human nasopharynx by pneumococcal strains and the 
colonized strains are prerequisite of invasive 
diseases7. Moreover, nasopharyngeal carriage of 
pneumococcal strains is an important risk factor as it 
is the major source of horizontal spread of this 
pathogen in both healthcare and community settings8. 
Therefore, understanding the carriage rate among 
carriers is important for the understanding of 
pneumococcal burden particularly in health-care 
settings9. Monitoring and surveillance of 
pneumococcal carriers in health-care settings seems to 
be essential for several reasons. First, carriers can 
serve as reservoirs for S. pneumoniae transmission to 
others in the hospital. Second, pneumococcal 
colonization in healthy persons is a risk factor to 
develop invasive and non-invasive pneumococcal 
diseases1. Horizontal transmission of pneumococcal 
strains to non-carriers occurs through direct contact 
with respiratory droplets from an asymptomatic 
carrier or a patient. Increased risk for developing the 
pneumococcal disease is documented in close contact 
between healthcare workers and unimmunized 
patients, including children younger than 2 years of 
age and patients with AIDS, sickle cell disease, certain 
immunodeficiency syndromes, asplenia and 
malignant neoplasms10. 
Management of severe S. pneumoniae infections is 
currently being compromised by increasing resistance 
of the pathogen to several antibiotics, which are 
commonly used for the treatment of pneumococcal 
diseases11,12. Several investigations of penicillin-
resistant pneumococci in the last years indicate that the 
emerging and spread of penicillin resistance is 
principally associated to spread of a few successful 
clones13. On the contrary, there is a lack of surveillance 
studies investigating fluoroquinolone resistance in 
several countries such as Iran. Although the incidence 
of levofloxacin-resistant pneumococci is reported to 
have increased throughout many parts of the world, the 
rate of such levofloxacin-resistance is unclear among 
pneumococcal strains in Iran. 
Therefore, the current study aimed to investigate the 
colonization rate of S. pneumoniae in healthcare 
workers who have constant contact with wide varieties 
of patients and to determine levofloxacin susceptibility 
for the pneumococcal isolates in Imam Hossein 
Hospital in Tehran. 
Methods 
Study population:This study was carried out from 
April to October 2018. A total of 300 healthcare 
workers from various hospital wards and departments 
of Imam Hossein Hospital, Tehran, Iran, who had direct 
contact with patients or handling clinical samples 
enrolled in our study. All grades of healthcare workers 
including nurses, cleaners, contract staff, graduates 
medical students, and interns were included in this 
study. The Ethics Committee of School of Medicine, 
Shahid Beheshti University of Medical Sciences 
approved this study (IR.SBMU.MSP.REC.1397.401). 
A written informed consent was obtained from all 
subjects before enrolling in this study. 
Sample collection and bacterial identification: The 
nasopharyngeal swab specimens were collected from 
volunteer healthcare workers of Imam Hossein Hospital 
who did not have any clinical evidence of infection and 
screened for S. pneumoniae by standard techniques. 
The collected swabs cultured for bacterial growth on 
tryptic soy agar plates (Merck Co., Germany) 
supplemented with 5% sheep blood followed by 
incubation for 24 hours at 37°C, 5% CO2. Phenotypic 
and conventional biochemical tests performed on 
suspected alpha-hemolytic colonies from blood agar. 
Gram stain, catalase and optochin (ethylhydrocupreine 
hydrochloride) susceptibility tests were carried out to 
identify S. pneumoniae isolates; when necessary, a bile 
(sodium deoxycholate) solubility test was also 
performed according to the standard procedure14.  
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Levofloxacin susceptibility testing: Susceptibility to 
levofloxacin evaluated in all pneumococcal isolates. 
The minimum inhibitory concentration (MIC) of 
levofloxacin was determined using a commercially 
available strip antibiotic test (Liofilchem Co., Roseto, 
Italy) according to the clinical laboratory standards 
institute (CLSI) guidelines 2018. The antibiotic 
susceptibility pattern of each pneumococcal isolates 
was analyzed based on the CLSI breakpoint for 
levofloxacin (MIC of ≤2 μg/ml, susceptible, MIC = 4 
µg/ml, intermediate resistance, and MIC of ≥4 μg/ml, 
resistant). 
Results 
Among the 300 healthcare workers enrolled during the 
study period, 19 (6.3%) had been colonized with S. 
pneumoniae. Amongst the enrolled volunteers, nurses 
had a higher rate of pneumococcal colonization 
(47.3%) followed by interns (21%) and laboratory 
workers (15.8%), while the lowest rate of colonization 
was found amongst the residents (5.2%).  
In this study, various potential risk factors for 
colonization also were analyzed. There was no 
significant association between gender/marital 
status/duration of employment in hospital/ previous 
history of upper respiratory tract infection/ previous 
history of pneumococcal diseases/ history of antibiotic 
intake in preceding 15 days or throat examination 
findings and pneumococcal colonization. Our analysis 
revealed that there was a significant correlation 
between smoking and pneumococcal colonization 
(p=0.001). Demographic characteristics and personal 
details of the healthcare worker volunteers, as well as 
the risk factors for pneumococcal colonization, 
summarized in Table 1. 
The antimicrobial susceptibility testing showed that 
all of the isolates were susceptible to levofloxacin 
(MIC≤2 μg/ml). The range of MIC against 
levofloxacin in pneumococcal isolates was between 
0.25 to 2 μg/ml, in which MIC50 and MIC90 values 
of levofloxacin were 1 μg/ml and 2 μg/ml, 
respectively. 
Discussion 
Asymptomatic nasopharyngeal colonization by 
encapsulated S. pneumoniae is very frequent, 
especially in children and healthcare workers, and the 
prevalence of carriers varies globally. It should be 
pointed out that nasopharyngeal colonization by 
pneumococcal strains is a prerequisite for 
pneumococcal infections15,16. The risk of 
nasopharyngeal colonization and pneumococcal 
infections increases with overcrowding, and 
hospitalization is an important risk factor for 
developing pneumococcal diseases17. Pneumococcus 
was previously reported to cause epidemics within 
closed populations and settings, including military 
bases, hospitals, daycare centers, shelters, jails, and 
nursing homes18. Moreover, S. pneumoniae is 
recognized as one of the causes of nosocomial 
infections, which is responsible for 5% of nosocomial 
bacterial meningitis, 4% of nosocomial acute sinusitis, 
and 2% of bacteremia and about 1% of nosocomial 
pneumonia19. As a matter of fact, cases of cross-
infection with S. pneumoniae in the hospital have been 
described in some specific age groups and debilitated 
individuals, such as the elderly, hospitalized neonates 
and infants, asplenic patients, and other 
immunocompromised patients and with ultimately fatal 
diseases20. The burden of nosocomial pneumococcal 
infections is reported to be significantly higher in 
developing countries21. Healthcare workers are 
considered as potential carriers for the transmission of 
pneumococcal strains. Moreover, medical students 
particularly could be potential source of pneumococcal 
infections in the community22. Therefore, 
comprehensive surveillance is essential to screen 
healthcare professionals and medical students for 
colonization by pneumococcal strains. 
Accurate data on the rate of carriage of pneumococci in 
healthy healthcare professionals in Iran are lacking. In 
this investigation, the rate of pneumococcal 
colonization in healthy healthcare workers in a teaching 
hospital in Tehran who do not suffer from 
pneumococcal infection was 6.3%. This colonization 
rate was less than those reported by Subramanya et al. 
in Nepal (30%)22. Mackenzie and colleagues reported 
that pneumococcal carriage prevalence was 26% 
among adults and 67% among children in Australia23. 
The differences in prevalence mentioned above can be 
explained by geographic variance, public 
immunization, and other risk factors. In Iran, there are 
a few data indicating pneumococcal carriage rate in 
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healthy children. Accordingly, Mousavi et al., 
reported that 26.7% of healthy in Tehran were 
colonized by S. pneumoniae24. In another 
investigation, 1300 healthy children less than 10 years 
old of age in Tehran were shown pneumococcal 
nasopharyngeal carriage rate of 44.1%25. 
Table 1: Demographic characteristics of the enrolled healthcare worker volunteers and also various risk factors for 
colonization with S. pneumoniae. 
Characteristics No. (%), 
N = 300 
Colonized, 
n = 19 (%) 
Not colonized, 































































Duration of employment in hospital 
>5 years  
5-10 years 
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Numerous studies have indicated that pneumococcal 
conjugate vaccines (PCVs) can prevent severe 
pneumococcal infections and induce herd immunity 
against the pathogen through colonization reduction in 
vaccinated individuals, and unvaccinated persons 
indirectly26. Accordingly, the pneumococcal 
colonization rate in the conjugate vaccine era has 
reported significantly lesser than the regions that do 
not have the pneumococcal immunization program27. 
To the extent of our knowledge, currently, there is no 
public immunization schedule against S. pneumoniae 
in Iran. Hence, pneumococcal vaccines are of 
particular importance in the reduction of 
pneumococcal colonization rates and pneumococcal 
diseases. Vaccination by PCVs appears to be the most 
effective approach in order to prevent occupational 
pneumococcal colonization and infections in 
healthcare workers. 
Smoking is established as an important independent 
risk factor for pneumococcal colonization and 
infection among adults. The high rate of 
pneumococcal colonization among smoker volunteers 
in our investigation was found. These findings are 
consistent with those reported by previous studies28,29. 
These data emphasize that exposure to smoke 
markedly increases the pneumococcal colonization 
rates and thus reducing smoking, tobacco 
consumption, and smoke exposure could reduce 
pneumococcal carriage. 
Antibiotic resistance among colonized pneumococci 
has can be used to predict response to antibiotic 
therapy of invasive pneumococcal disease30. Peterson 
et al., in 2009 described that 96–99% of multidrug-
resistant S. pneumoniae (MDRSP) strains were 
susceptible to levofloxacin; thus, levofloxacin was 
introduced as an effective antimicrobial against these 
isolates 31. However, in recent years, a trend towards 
the increasing emergence and spread of levofloxacin 
non-susceptibility has been reported in Asian 
countries32,33. In contrast with these data, our finding 
indicated that the levofloxacin non-susceptibility rate 
was 0% among S. pneumoniae isolates. Therefore, in 
vitro levofloxacin susceptibility assay showed that 
levofloxacin has remained effective for the treatment 
of pneumococcal infections. In light of these results, 
previously, a study conducted by Houri et al. showed 
no levofloxacin-resistant S. pneumoniae isolate in 
pediatric patients12. 
Conclusion 
This low rate of pneumococcal colonization amongst 
healthcare professionals may be attributed to a low risk 
of horizontal transmission of severe pneumococcal 
infections in the hospital. A strategy of continuous 
surveillance of pneumococcal colonization among 
healthcare workers and medical students could help to 
predict the transmission of pneumococcal infections in 
healthcare settings. Therefore, regular screening 
programs and restriction of colonized healthcare 
professionals should be implemented particularly in 
high-risk units in order to minimize the transmission of 
severe pneumococcal infections. In addition, an 
appropriate immunization of healthcare workers using 
PCVs is recommended to reduce pneumococcal 
carriage and therefore pneumococcal diseases. Finally, 
according to our findings levofloxacin has remained an 
effective antimicrobial agent for the treatment of 
pneumococcal infections. 
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